Logo for Idorsia Ltd

Idorsia Investor Relations Material

Latest events

Logo for Idorsia Ltd

FDA Announcement

Idorsia
Logo for Idorsia

FDA Announcement

20 Mar, 2024
Logo for Idorsia

Q3 2023

24 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Idorsia Ltd

Access all reports
Idorsia Ltd is a biopharmaceutical company based in Switzerland, specializing in the discovery, development, and commercialization of small molecules. The company targets a wide range of diseases, including Fabry disease, insomnia, resistant hypertension, cerebral vasospasm, epilepsy, nasal polyposis, and systemic lupus erythematosus, among others. Idorsia's approach spans multiple therapeutic areas such as CNS, cardiovascular, and immunological disorders, as well as orphan diseases. The company is headquartered in Allschwil, near Basel, Switzerland, and its shares are listed on the SIX Swiss Exchange.